Llwytho...
Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke
BACKGROUND: Stroke is a leading cause of long‐term disability worldwide. However, current therapies that promote functional recovery from stroke are limited to physical rehabilitation. No pharmacological therapy is available. Thus, understanding the role of histone deacetylase 2 (HDAC2) in the patho...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Am Heart Assoc |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5721897/ https://ncbi.nlm.nih.gov/pubmed/28982677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.007236 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|